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Abstract 
The present investigation was carried out to study the active component of 
Bacillus subtilis, a gastrointestinal bacterium of mrigal (Cirrhinus mrigala) that 
shows inhibitory activity against a wide range of fish pathogens. The 
bacterium was found to inhibit all the fish pathogens and an extra cellular 
protein fraction (ECP) of 5-10 kD was found to be the active component 
responsible for inhibitory activity. The component was heat stable (60°C for 1 
h) and a change in pH had no effect on the antibacterial activity. The protein 
fraction was sensitive to trypsin, chymotrypsin, lysozyme, and proteinase K at 
2.5 mg/ml and resistant at 0.1 and 0.5 mg/ml. The present investigation 
confirmed that the active component of the B. subtilis responsible for 
antibacterial activities against common fish pathogens is a low molecular 
weight protein fraction (5-10 kD). A protein or peptide with such a low 
molecular weight has the potential to serve as an alternative health 
management strategy for combating disease in aquaculture. 
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Introduction 
The emergence of new pathogens and antibiotic resistance among pathogens threatens 
all forms of life including aquatic organisms. Therefore, much attention is being paid to 
new sources of anti-microbial and therapeutic agents (Clardy et al., 2006). Being a 
natural source of anti-microbial agents, microorganisms are often exploited to control 
infectious agents. Bacteria normally inhibit other bacteria by producing a variety of 
bactericidal and/or bacteriostatic metabolites. These compounds are mainly antibiotics, 
small peptides, metabolites such as alehydes, hydrogen peroxide, carbon dioxide, or lytic 
agents such as lysozyme (Tagg et al., 1976; Ray, 1992; Jack et al., 1995; Hutter et al., 
2004). 
 Among the bacterial genera with potent antimicrobial agents, the gram-positive 
Bacillus species have the potential to produce many kinds of antimicrobial compounds 
including bacitracin, pumulin, and gramicidin (Todar, 2005). Bacillus subtilis has received 
particular attention due to its nonpathogenic nature and ability to produce antimicrobial 
peptides (Korenblum et al., 2005; Huang et al., 2006; El-hamshary and Khattab 2008). 
 A wide range of antibiotics, drugs, and chemicals are routinely used to control 
diseases in aquaculture. The indiscriminate use of such agents often leads to the 
development of resistance to antibiotics. The recent concept of disease management is to 
replace antibiotic therapy with probiotics or new compounds capable of inhibiting a wide 
range of pathogens (Ramakrishnan et al., 2008; Ganguly et al., 2010). The present 
investigation was carried out to partially purify and characterize the inhibitory substance 
of Bacillus subtilis, a gastrointestinal bacterium of mrigal (Cirrhinus mrigala), that 
possesses immunomodulatory (Nayak et al., 2007) and antibacterial activities against 
common fish pathogens. 
   
Materials and Methods 
Bacillus subtilis, a gastrointestinal bacterium isolated from mrigal (C. mrigala) along with 
five bacterial pathogens (Aeromonas hydrophila, Edwardsiella tarda, Pseudomonas 
aeruginosa, Pseudomonas fluorescens, Flavobacterium branchiophilum) and four 
opportunistic pathogens (Salmonella, Shigella, Escherichia coli, Staphylococcus) were 
obtained from the Fish Health Management Division of the Central Institute of Freshwater 
Aquaculture in Orissa, India, and screened. 
 The inhibitory activity of the bacteria was screened in vitro in an inhibition test on 
solid medium as per the double layer method of Dopazo et al. (1988) with slight 
modifications. The bacterium was first grown in tryptone soya broth (TSB) at 30°C for 24 
h, then cultures were spot-inoculated into tryptone soya agar plates and incubated at 
30°C for 120 h to create a macro colony. After incubation the cells were killed with 
chloroform vapor (15-20 min) and an overlay containing pathogenic strains was poured 
over the plates (5 ml/plate). The plates were incubated up to 120 h at 30°C and the 
zones of inhibitions around the macro colony were recorded. 
 A well diffusion assay was carried out as follows: tryptone soya agar (TSA) plates 
were prepared and wells (6 mm diameter) were made by puncture. The lower end of the 
plates was sealed with molten agar and the pathogens were swabbed on the plates. 
About 100 ml of the test sample was poured into the wells which were incubated 24-48 h 
at 30°C. Inhibition zones were recorded up to 120 h.  
 The inhibitory activity of the bacteria was further evaluated by growing the bacteria in 
brain heart infusion agar (BHIA), diagnostic sensitive agar (DSA), nutrient agar (NA), and 
TSA, procured from Hi-media, India. Next, the effects of temperature (22-37°C), pH 
(5.5-8.5), and salt concentration (0-10%) on inhibitory activity were studied on TSA. 
 To screen the inhibitory activity of the extra cellular product (ECP) of B. subtilis, the 
bacteria was grown in TSB for 72 h at 30°C, the supernatant was collected by 
centrifuging the culture at 10,000 × g for 10 min at 4°C, and the supernatant was filter 
sterilized in 0.22 nm membrane filters (Satorius, Germany) and serially passed through 
protein filters with cut-off values of 5, 10, 20, and 100 kD (Satorius, Germany). Finally, 
the inhibitory activity of the crude ECP, along with individual fractions of the ECP 
component, was tested at different temperatures and pH by the well diffusion method 
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described above. ECP samples were heat-inactivated in water baths at 60°C for 15 min, 
60°C for 30 min, 60°C for 1 h, 100°C for 15 min, or 121°C for 15 min and the activity 
was tested by well diffusion assay. ECP samples were kept at -20°C, 4°C, and room 
temperature (27-34°C) for six months and the inhibitory activity was checked every 15 
days by well diffusion assay. 
 The enzymes trypsin, chymotrypsin, lysozyme, proteinase K, lipase, DNase, and 
RNase (Sigma, USA) were added to the active fraction at 0.1, 0.5, and 2.5 mg/ml, the 
mixtures were incubated 1 h at 37°C, the enzymes were inactivated at 56°C for 30 min, 
and the antibacterial activity of the mixtures as well as the pure enzymes was tested by 
the disc diffusion method. 
 
Results 
The bacteria produced inhibitory activity against all the tested fish pathogens and 
secondary pathogens in all the media. The inhibition was significantly greater in the TSA 
and BHIA media than in the NA and DSA media and greatest when the bacterium was 
grown in TSA with a 1% salt concentration, pH 7, and 30°C. The least inhibitions were 
recorded at pH 5.5 and 8.5, with no significant difference in zone size. 
 The crude ECP component of B. subtilis inhibited all the tested pathogens. Formost 
pathogens, inhibitory activity was significantly better at 30°C and pH 7 (Table 1). The 
protein fractions <5, 20, and >100 kD showed no inhibitory activity against any tested 
primary or secondary pathogen, however, the 5-10 kD fraction inhibited all. Crude and 5-
10 kD protein activity was recorded at 60°C/30 min and 60°C/1 h, however, no inhibitory 
zones were detected at 100°C/15 min or 121°C/15 min. 
 Inhibitory activity was observed in the crude ECP and 5-10 kD protein fraction after  
six months in storage at -20°C, 4°C, and room temperature (27-34°C). The best activity 
was recorded in samples kept at room temperature while the least, but not significantly 
least, activity was in samples stored at -20°C for six months for both crude B. subtilis 
and its 5-10 kD protein ECP 
component. 
 Inhibitory activity of the ECP 
component was detected when treated 
with trypsin, chymotrysin, lysozyme, 
and proteinase K at 0.1 and 0.5 
mg/ml, but no activity was recorded 
when treated with these enzymes at 
2.5 mg/ml (Table 2). Activity was 
detected in both crude B. subtilis and 
the pure ECP component when treated 
with lipase, RNAase, and DNAase 
irrespective of the enzyme 
concentration. 
 
    Table 1. Zones of inhibition (mean±SD) exerted by the ECP component of Bacillus subtilis on 
various fish pathogens at different temperatures and pH. 
 
Strain* 
37°C (pH) 30°C (pH) 22°C (pH) 
5.5 7 8.5 5.5 7 8.5 5.5 7 8.5 
Ah1 1.17±0.17b 1.52±0.09c 0.87±0.22a 1.0±0.08ab 1.62±0.05c 0.92±0.18a 0.92±0.12a 1.20±0.08b 0.80±0.18a 
Ah2 1.07±0.17b 1.82±0.12c 0.92±0.09b 1.02±0.09b 1.8±0.14c 0.92±0.09b 0.65±0.10a 1.60±0.08c 0.67±0.05a 
Ah3 0.77±0.05a 1.45±0.1cd 1.07±0.15b 0.97±0.17b 1.47±0.12d 1.00±0.14b 0.75±0.23a 1.20±0.05c 1.05±0.05bc 
Ah4 1.15±0.1bc 1.62±0.12e 1.17±0.17bc 1.32±0.12cd 1.80±0.16e 1.15±0.1bc 0.85±0.12a 1.40±0.05d 1.12±0.09b 
Et 1.15±0.1b 1.47±0.05c 1.17±0.12b 1.20±0.01b 1.52±0.09c 1.20±0.08b 0.92±0.09a 1.15±0.05b 0.87±0.12a 
Pa 1.1±0.08bc 1.32±0.05d 1.12±0.12bc 1.02±0.09b 1.42±0.05d 1.12±0.12bc 0.77±0.05a 1.17±0.05c 0.82±0.09a 
Pf 1.17±0.05c 1.32±0.09d 1.12±0.05c 1.12±0.05c 1.45±0.05e 1.10±0.01c 0.97±0.09b 0.95±0.1b 0.77±0.05a 
Fbr 1.17±0.18c 1.82±0.2d 0.87±0.09ab 1.10±0.18c 1.75±0.12d 1.12±0.15c 1.02±0.09bc 1.65±0.12d 0.80±0.08a 
Different superscripts in a row indicate significant differences. 
* Ah1, Ah2, Ah3, Ah4 = four strains of Aeromonas hydrophila; Et = Edwardsiella tarda; Pa = Pseudomonas 
aeruginosa; Pf = Pseudomonas fluorescens; Fbr = Flavobacterium branchiophilum 
 
    Table 2. The effect of different enzymes on the 
antibacterial activity of the 5-10 kD protein fraction of 
the ECP component of Bacillus subtilis. 
 
 Enzyme concentration (mg/ml) 
Enzyme 0.1 and 0.5 2.5 
 Enzyme 
only 
ECP 
only 
Both 
Enzyme 
only 
ECP 
only 
Both 
Trypsin + + + + + - 
Chymotrypsin + + + + + - 
Lysozyme + + + + + - 
Proteinase K + + + + + - 
RNAsae - + + + + + 
DNAse - + + + + + 
Lipase - + + + + + 
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Discussion 
Bacillus subtilis is one of the dominant producers of antibiotics and anti-microbial 
compounds of the Bacillus genus. The broad spectrum inhibitory activity of B. subtilis has 
been reported against pathogens of humans and animals, including fish and shellfish. 
During, the present investigation B. subtilis inhibited all the tested pathogens and 
secondary pathogens. The 5-10 kD protein fraction of the ECP component was 
responsible for the inhibitory activity. Similarly, a heat labile sideraphore of less than 5 
kD was the active component of a Bacillus species isolated from fish (Sugita et al. 
(1998). The component was soluble, extracellular and diffusible, in accordance with the 
findings of Fiddaman and Rossal (1993). 
 Various proteolytic enzymes such as proteinase K, trypsin, α-chymotrypsin (type II), 
and protease (type XIV), when treated at 0.1 mg/ml, had no effect on the antibacterial 
activity in the culture supernatant of Bacillus species (Sugita et al., 1998). In the present 
investigation, the ECP component of B. subtilis resisted these enzymes up to 0.5 mg/ml 
but not at 2.5 mg/ml. This characteristic is typical of gram-positive bacteria (Ray, 1992; 
Jack et al., 1995). 
 The present investigation confirms that the active component responsible for the 
antibacterial activity of the bacterium B. subtilis against common fish pathogens is a low 
molecular weight ECP protein fraction (5-10 kD). This low molecular weight 
protein/peptide has potential as an alternative health management practice for 
combating disease in aquaculture. However, in vivo studies, especially with respect to 
dose, route of supplementation, and efficacy of such compound(s) in a piscine system, 
are warranted. 
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